U.S. generic drugmaker Mylan Laboratories Inc. said on Monday it would buy up to 71.5% of Matrix Laboratories Ltd. for about $735 million in India’s biggest drug industry takeover as it seeks to expand into emerging markets.
*For more on this story,
read the full Reuters article.
